Tantangan Diagnosis Dan Tatalaksana Glucocorticoid Withdrawal Syndrome Dengan Diagnosis Banding Sindrom Cushing: Sebuah Laporan Kasus
DOI:
https://doi.org/10.56260/sciena.v4i6.285Keywords:
Adrenal insufficiency, Cushing's syndromeAbstract
Glucocorticoid withdrawal syndrome (GWS) presents a significant diagnostic and therapeutic challenge due to overlapping clinical features with Cushing's syndrome. We report the case of a 52-year-old man who presented with severe joint pain, swelling, myalgia, anorexia, nausea, and notable clinical features including moon face, central obesity, and violaceous striae, suggestive of chronic glucocorticoid exposure. His medical history revealed long-term, unsupervised glucocorticoid use through over-the-counter analgesics. Laboratory investigations demonstrated progressive leukocytosis, marked neutrophilia, elevated procalcitonin levels indicative of systemic infection, significant electrolyte disturbances (hyponatremia, hypokalemia), impaired glucose metabolism, and moderate renal dysfunction. Cardiac evaluation revealed atrial fibrillation with rapid ventricular response, congestive heart failure, and left ventricular hypertrophy, consistent with chronic glucocorticoid exposure complications. Initial basal cortisol testing showed normal-low levels, necessitating further confirmation through ACTH stimulation testing to differentiate between glucocorticoid-induced adrenal insufficiency and endogenous hypercortisolism. Management strategies included carefully tapered intravenous glucocorticoids transitioning to oral methylprednisolone, intensive insulin therapy for glycemic control, aggressive treatment of infection, and meticulous fluid-electrolyte management, resulting in clinical and biochemical improvement. The complexity of this case underscores the necessity for a thorough, multidisciplinary approach involving endocrinologists, cardiologists, internists, and nutritionists to ensure optimal management of GWS, prevent adrenal crises, and mitigate long-term cardiovascular and metabolic complications
References
. Nizami S, Mohan M, Bhasker AG, et al. Hidden steroids in over-the-counter analgesic and herbal preparations: A public health threat. J Family Med Prim Care. 2020;9(6):2924-2929. doi:10.4103/jfmpc.jfmpc_270_20.
. Husain A, Haroon TS. Iatrogenic Cushing’s syndrome due to ‘herbal’ steroid use: A case report and review. J Pak Assoc Dermatol. 2019;29(1):102-105.
. World Health Organization. Global Report on Traditional and Complementary Medicine 2019. Geneva: World Health Organization; 2019. Available from: https://www.who.int/publications/i/item/9789241515436
. Broersen LHA, Pereira AM, Jørgensen JOL, Dekkers OM. Adrenal insufficiency in corticosteroids use: Systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100(6):2171-2180. doi:10.1210/jc.2015-1218.
. Charmandari E, Nicolaides NC, Chrousos GP. Adrenal Suppression — Exogenous Glucocorticoids and the Hypothalamic-Pituitary-Adrenal Axis. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279156/
. Inder WJ, Hunt PJ. Glucocorticoid withdrawal syndrome: What to expect and how to manage. Eur J Endocrinol. 2024;190(5):G25-G34. doi:10.1530/EJE-23-0604.
. Younes A, Alzahrani AS, Aljomaiah A, et al. Recovery of steroid-induced adrenal insufficiency. Transl Pediatr. 2021;10(10):2748-2757. doi:10.21037/tp-20-189.
. Pofi R, et al. Glucocorticoid withdrawal syndrome: Pathophysiology, diagnosis, and management. Endocrine. 2023;81(1):1–13.
. Hahner S, et al. Adrenal crisis and glucocorticoid withdrawal: Pathophysiology and management. Eur J Endocrinol. 2020;182(3):C1–C10.
. Terzolo M, et al. Cushing’s syndrome: Pathophysiology, diagnosis, and treatment. Nat Rev Endocrinol. 2020;16(10):548–60.
. Fleseriu M, Hashim IA, Karavitaki N, et al. Hormonal withdrawal and glucocorticoid-induced adrenal insufficiency. Endocr Rev. 2021;42(5):575-601.
. Marik PE, Pastores SM, Annane D. Critical illness–related corticosteroid insufficiency (CIRCI): An international task force report. Intensive Care Med. 2020;46(6):1051–67.
. Owen K, Moser J, Faiman C. Glucocorticoid-induced adrenal insufficiency and glucocorticoid withdrawal syndrome. Consult QD, Cleveland Clinic. 2024. Available from: https://consultqd.clevelandclinic.org/glucocorticoid-induced-adrenal-insufficiency-and-glucocorticoid-withdrawal-syndrome
. He, X., Findling, J.W. and Auchus, R.J., 2022. Glucocorticoid withdrawal syndrome following treatment of endogenous Cushing syndrome. Pituitary, 25(3), pp.393–403. https://doi.org/10.1007/s11102-022-01218-y
. Pelewicz, K. and Miśkiewicz, P., 2021. Glucocorticoid Withdrawal—An Overview on When and How to Diagnose Adrenal Insufficiency in Clinical Practice. Diagnostics, 11(4), p.728. https://doi.org/10.3390/diagnostics11040728
. Kiełczewska, A., Szcześniak, G. and Kiełczewska, A., 2024. Diagnosis and approach to glucocorticoid-induced adrenal insufficiency and glucocorticoid withdrawal syndrome. Journal of Education, Health and Sport, 70, Article 55790. https://doi.org/10.12775/JEHS.2024.70.55790
. Nieman LK, et al. The diagnosis of Cushing’s syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93(5):1526-40.
. Torpy, D.J. and Lim, W.T., 2023. Glucocorticoid-induced adrenal suppression: physiological basis and strategies for glucocorticoid weaning. The Medical Journal of Australia, 219(10), pp.444–447. https://doi.org/10.5694/mja2.52140
. Borresen, S.W., Klose, M., Glintborg, D., Watt, T., Andersen, M.S. and Feldt-Rasmussen, U., 2022. Approach to the Patient With Glucocorticoid-induced Adrenal Insufficiency. The Journal of Clinical Endocrinology & Metabolism, 107(7), pp.2065–2076. https://doi.org/10.1210/clinem/dgac151
. Marik PE, Pastores SM, Annane D. Critical illness–related corticosteroid insufficiency (CIRCI): An international task force report. Intensive Care Med. 2020;46(6):1051–67.
. Savas, M., Mehta, S., Agrawal, N., van Rossum, E.F.C. and Feelders, R.A., 2022. Approach to the patient: diagnosis of Cushing syndrome. The Journal of Clinical Endocrinology & Metabolism, 107(11), pp.3162–3174. https://doi.org/10.1210/clinem/dgac492
. Caplan, A., Fett, N., Rosenbach, M., Werth, V.P. and Micheletti, R.G., 2017. Prevention and management of glucocorticoid-induced side effects: A comprehensive review. Journal of the American Academy of Dermatology, 76(1), pp.11–16. https://doi.org/10.1016/j.jaad.2016.02.1239
. DeMorrow, S., 2018. Role of the hypothalamic–pituitary–adrenal axis in health and disease. International Journal of Molecular Sciences, 19(4), p.986. https://doi.org/10.3390/ijms19040986
. Udelsman R, et al. Glucocorticoid physiology and clinical implications during critical illness. J Clin Endocrinol Metab. 2022;107(1):12–24.
. Arlt W, et al. Adrenal insufficiency and CIRCI in sepsis and critical illness. Nat Rev Endocrinol. 2020;16(7):409–21.
. Pelewicz B, Miśkiewicz P. Diagnostic challenges in secondary adrenal insufficiency: New insights. Front Endocrinol. 2021;12:702138.
. Husebye ES, et al. Adrenal insufficiency—Diagnosis and management. Clin Med (Lond). 2023;23(1):10–17.
. Kline GA, Buse P. Interpretation of the short synacthen test: Does timing matter? Clin Endocrinol (Oxf). 2022;96(1):36–43.
. Hurtado, M.D., Cortes, T., Natt, N., Young, W.F. and Bancos, I., 2018. Hypothalamic-pituitary-adrenal axis recovery after adrenalectomy for corticotropin-independent cortisol excess. Clinical Endocrinology. https://doi.org/10.1111/cen.13803
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Made Adikosha Pranata, Wira Gotera, Ida Bagus Aditya Nugraha, Karlina Isabella, Ni Made Dwi Adnyani, Ni Wayan Meindra Wirtayani

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
